According to filings with the U.S. Securities and Exchange Commission, Cureatr is raising $9,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Richard Resnick played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cureatr
Cureatr is a thriving, medication management telepharmacy clinic, headquartered in Manhattan, but largely virtually distributed, committed to tackling the $528B suboptimal medication management problem. We help health plans, healthcare organizations, and patients make sure medications are taken appropriately, effectively, and most of all, safely. We do it with our army of board-approved, residency trained, clinical telepharmacists, armed with years of expertise in medication administration safety and effectiveness, working night and day on the phone, video, email, and secure text message. We do it with unparalleled software and real-time data on patients clinical backgrounds and medication histories, because we believe that when patient medication data is simple, accessible, and transparent at the point of care, patients can be treated from the big picture of overall health and happiness.

To learn more about Cureatr, visit http://www.cureatr.com/

Contact:
Richard Resnick, Chief Executive Officer
646-661-5168
https://www.linkedin.com/in/richardresnick/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.